Clinical Trials Directory

Trials / Completed

CompletedNCT05533307

Mediolateral Episiotomy in Nulliparous Women Increases the Risk of Sexual Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Batman Training and Research Hospital · Other Government
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers

Summary

Postpartum sexual functions may be affected in women who have had a vaginal delivery by performing an episiotomy. The aim of this study is to compare the frequency of sexual dysfunction between women who were delivered with a mediolateral episiotomy and those who were delivered without an episiotomy. Materials and Methods: A total of 179 women who gave birth in a tertiary center were included in the prospective study. The patients were divided into two groups as women with and without mediolateral episiotomy. The groups were compared in terms of age, body mass index, educational status, and hospitalization time for delivery and Arizona sexual experiences scale (ASEX).

Detailed description

All patients were called up for a control in 6th month after delivery and sexual funciton was evaluated according to The Arizona Sexual Experience Scale (ASEX). In our study, we used the ASEX test, age, education level, BMI and time spent in hospital for delivery to investigate sexual dysfunction in healthy women who had a vaginal delivery with or without mediolateral episiotomy. The ASEX test is a 5-question survey. In the questionnaire, women were questioned for sexual drive, arousal, vaginal lubrication, ability to reach orgasm, satisfaction from the orgasm. Women gave points from 1 to 6 and their results were recorded.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTobservational analysis of mediolateral episiotomy with arizona sexuel function scoring after 3 months of normal vaginal birthASEX (ARİZONA SEXUEL FONCTİON SCORİNG) TEST

Timeline

Start date
2019-09-10
Primary completion
2021-09-15
Completion
2022-08-08
First posted
2022-09-09
Last updated
2022-09-13

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05533307. Inclusion in this directory is not an endorsement.